Q+A: How CEPI-funded research is supporting the COVID-19 vaccine rollout 19 Jul 2022 14 min read verified Cross-postsDataResearch summaryCOVID-19
Further vaccine R&D is critical to end the devastating COVID-19 pandemic 5 Oct 2021 3 min read verified COVID-19COVAXCross-posts
“We are not resting on our laurels”: COVID-19 survivors encourage vaccination in Nigeria 16 Sep 2021 4 min read verified COVID-19COVAX
From town criers to local monarchs: encouraging COVID-19 vaccination in Southern Nigeria 21 Jul 2021 4 min read verified COVID-19COVAX
To keep coronavirus at bay, we must create a ‘variant-proof’ world 10 Jun 2021 6 min read verified COVID-19COVAXCross-postsExplainer
Speeding up vaccine development: Can we go from lab to jab in just 100 days? 8 Jun 2021 5 min read verified Cross-postsCOVID-19Vaccine developmentCOVAX
COVAX Manufacturing Task Force to tackle vaccine supply challenges 14 May 2021 4 min read verified InnovationCOVID-19COVAXCross-posts
Going universal: The search for an all-in-one coronavirus vaccine 29 Mar 2021 8 min read verified COVID-19VideosCross-postsExplainer
The importance of blood markers in assessing vaccine efficacy 27 Jan 2021 4 min read verified COVID-19Cross-postsExplainer
Ensuring safety of COVID-19 vaccines 25 Nov 2020 11 min read verified COVAXCOVID-19Cross-postsVaccine safety
CEPI expands global manufacturing network, reserving manufacturing capacity for more than 1 billion doses of COVID-19 vaccines 26 Oct 2020 6 min read verified COVAXCOVID-19Cross-posts
Why we need a “portfolio approach” to COVID-19 vaccine development 20 Oct 2020 5 min read verified COVID-19Cross-postsVaccine development
How to measure the success of a COVID-19 vaccine? 31 Aug 2020 6 min read verified COVID-19COVAXCross-postsExplainer